Search

Henryk K Cudny

from Bay Point, CA
Age ~83

Henryk Cudny Phones & Addresses

  • 1082 Oakpoint Dr, Pittsburg, CA 94565 (925) 709-1485
  • Bay Point, CA
  • Newark, CA
  • 1545 Solitude Way, Brentwood, CA 94513 (925) 392-8073
  • Westminster, CO
  • Concord, CA

Industries

Biotechnology

Resumes

Resumes

Henryk Cudny Photo 1

Retired

View page
Location:
1082 Oakpoint Dr, Bay Point, CA 94565
Industry:
Biotechnology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Henryk Cudny
Manager
Nuvelo Incorporated
Research and Development in the Physical, Engineering, and L · In-Vitro Diagnostic Substance Manufacturing · Research & Development in Biotechnology
201 Industrial Rd, San Carlos, CA 94070
(650) 591-2302, (650) 517-8000, (650) 517-8001

Publications

Us Patents

Methods For Increasing Yields Of Recombinant Proteins

View page
US Patent:
59143908, Jun 22, 1999
Filed:
May 12, 1997
Appl. No.:
8/855774
Inventors:
Ranga Nathan - Danville CA
Henryk Cudny - Concord CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Santa Clara CA
International Classification:
C07K 100
C07K 1400
C12N 1500
US Classification:
530380
Abstract:
Methods are disclosed for increasing the yields of recombinant proteins. Addition of one or more protective agents, such as a sulfated compound (including heparin, heparin sulfate, sodium dodecyl sulfate, and the like), hyaluronic acid or deoxycholate, to recombinant protein production processes is disclosed. Addition of protective agents to the recombinant production process results in increased yields of recombinant proteins.

Production Of Recombinant Human Interleukin-1 Inhibitor

View page
US Patent:
54534909, Sep 26, 1995
Filed:
Aug 30, 1994
Appl. No.:
8/298180
Inventors:
Robert Hageman - Boulder CO
Stephen P. Eisenberg - Boulder CO
David Dripps - Boulder CO
Ronald Evans - Louisville CO
Henryk Cudny - Boulder CO
Robert C. Thompson - Boulder CO
Assignee:
Synergen, Inc. - Boulder CO
International Classification:
C07K 14435
C07K 118
C07K 136
US Classification:
530350
Abstract:
A method for the production of commercial quantities of highly purified interleukin-1 inhibitor (IL-1i) from a recombinant host is disclosed. A preferred recombinant E. coli host for use in this method is also disclosed.
Henryk K Cudny from Bay Point, CA, age ~83 Get Report